A 2026 expert consensus issued by the Endoscopy Group of General Surgery and the Gastric Cancer Committee of the Chinese Anti-Cancer Association has provided a comprehensive framework for diagnostic laparoscopic exploration in gastric cancer staging. The consensus addresses a critical limitation of conventional imaging: both CT and PET-CT may fail to detect small-volume peritoneal metastases, especially early peritoneal seeding or microscopic dissemination.
Diagnostic laparoscopy allows direct visualization of:
Primary tumor extent
Perigastric lymph nodes
Peritoneal surfaces
Diaphragmatic reflections
Pelvic peritoneum and omentum
The procedure also facilitates:
Targeted biopsy of suspicious lesions
Peritoneal lavage cytology
Detection of occult metastatic disease not visible radiologically
The consensus outlines:
Indications and contraindications
Standard trocar positioning
Systematic exploration sequence
Biopsy techniques
Cytology collection protocols
Documentation standards
Importantly, the document issues 12 formal recommendations aimed at reducing institutional variability and improving staging consistency across gastric cancer centers.
For patients with locally advanced gastric cancer, staging laparoscopy should be viewed as a decision-altering procedure rather than an optional adjunct investigation. Accurate identification of occult peritoneal metastasis may prevent:
Non-therapeutic laparotomy
Futile radical gastrectomy
Inappropriate neoadjuvant-to-surgery pathways
The consensus reinforces the growing role of minimally invasive staging in precision oncologic decision-making.
Upper-GI and laparoscopic oncologic surgeons should consider diagnostic laparoscopy particularly in:
T3/T4 gastric cancers
Diffuse-type gastric carcinoma
Signet-ring histology
Equivocal imaging findings
Patients being considered for curative-intent resection
The publication highlights the importance of structured laparoscopic staging protocols to improve treatment selection and avoid understaging.
Source: PubMed Study
A review published in Zhonghua Wei Chang Wai Ke Za Zhi examined minimally invasive gastrectomy following neoadjuvant therapy for locally advanced gastric cancer, focusing on the technical challenges encountered during post-treatment dissection.
Neoadjuvant chemotherapy and combined treatment protocols often produce:
Dense fibrosis
Tissue edema
Inflammatory adhesions
Lymph-node remodeling
Distortion of normal tissue planes
These changes significantly increase the complexity of:
Suprapancreatic lymphadenectomy
Splenic hilar dissection
Vessel skeletonization
D2 lymph node clearance
The review compares laparoscopic and robotic approaches and suggests that robotic systems may provide technical advantages in difficult post-neoadjuvant dissections because of:
Three-dimensional magnified visualization
Wristed articulated instruments
Tremor filtration
Improved ergonomics
Enhanced precision around major vascular structures
Technical Pearl Highlighted
The authors specifically emphasize the value of Maryland forceps for:
Fine retrovascular dissection
Maintenance of tissue planes
Nerve preservation
Delicate lymphovascular handling
Compared with routine extensive energy-device use, Maryland-based meticulous dissection may reduce collateral thermal injury and improve precision in fibrotic operative fields.
Important Oncologic Principle
The review strongly cautions against compromising oncologic radicality simply because neoadjuvant therapy has made the operation technically more demanding. D2 lymphadenectomy standards should be maintained despite fibrosis and inflammation.
Clinical Relevance
This review is particularly relevant for advanced laparoscopic and robotic upper-GI surgeons managing post-neoadjuvant gastric cancer. In these operations, success is frequently determined not only by technical skill, but by:
Preservation of proper embryologic planes
Safe vascular dissection
Maintenance of oncologic completeness
Avoidance of pancreatic and splenic injury
The article reinforces the evolving role of robotic platforms as precision tools in technically hostile oncologic environments rather than merely ergonomic alternatives to laparoscopy.
Source: PubMed Study